Clinical trial
Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
NCT00304811 · Michael E. DeBakey VA Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00304811 |
|---|---|
| Title | Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection |
| Official title | Vancomycin Versus Vancomycin Plus Gentamycin For Treating Bacteremic Infection Due to Methicillin-Resistant Staphylococcus Aureus (MRSA) |
| Lead sponsor | Michael E. DeBakey VA Medical Center, U.S. Fed |
| Collaborators | Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Staphylococcus Aureus |
| Intervention type | Drug |
| Interventions | Vancomycin, Vancomycin plus Gentamicin, Vancomycin plus Rifampin, Vancomycin plus Gentamicin plus Rifampin |
| Enrollment | 160 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Mar 20, 2006 |
| Last update posted | Sep 28, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: